During the past decade, Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Achieve Life Sciences" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "BeiGene" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" #1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator, "Linical Europe GmbH" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Non-Small Cell Lung Cancer" (3 trials), "Lung Cancer" (2 trials), "Non-small Cell Lung Cancer" (2 trials) and "Carcinoma, Transitional Cell" (1 trials). Many other conditions were trialed in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" are "Drug" (18 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Docetaxel" (4 trials), "Pemetrexed" (4 trials), "Placebo" (4 trials) and "Amivantamab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc has several departments that took part in Clinical trials: "Warminsko-Mazurskie Centrum Chorób Płuc w Olsztynie; Oddzial onkologii z pododdzialem chemioterapii" - 12 trials